Clinical Trial Update: An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

View source ↗

Summary

An observational study to evaluate the effectiveness and safety of cemiplimab in adults with advanced non-small cell lung cancer in routine European clinical pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Libtayo (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Non-small Cell Lung Cancer | Status: RECRUITING